Ibrutinib, Obinutuzumab and Venetoclax for Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT03755947 · COMPLETED

Trial details

NCT number: NCT03755947
Sponsor: Grupo Cooperativo de Hemopatías Malignas
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

B-Cell Chronic Lymphocytic Leukemia B-Cell Chronic Lymphocytic Leukemia in Relapse (Diagnosis)

Start date: 2018-12-01
Primary completion: 2020-12-31
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.